1. Home
  2. ETON vs EM Comparison

ETON vs EM Comparison

Compare ETON & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • EM
  • Stock Information
  • Founded
  • ETON 2017
  • EM 2017
  • Country
  • ETON United States
  • EM China
  • Employees
  • ETON N/A
  • EM N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • EM Other Consumer Services
  • Sector
  • ETON Health Care
  • EM Consumer Discretionary
  • Exchange
  • ETON Nasdaq
  • EM Nasdaq
  • Market Cap
  • ETON 329.8M
  • EM 298.5M
  • IPO Year
  • ETON 2018
  • EM 2021
  • Fundamental
  • Price
  • ETON $14.22
  • EM $1.12
  • Analyst Decision
  • ETON Strong Buy
  • EM Strong Buy
  • Analyst Count
  • ETON 3
  • EM 1
  • Target Price
  • ETON $27.67
  • EM $1.00
  • AVG Volume (30 Days)
  • ETON 248.9K
  • EM 291.1K
  • Earning Date
  • ETON 03-18-2025
  • EM 03-06-2025
  • Dividend Yield
  • ETON N/A
  • EM 2.35%
  • EPS Growth
  • ETON N/A
  • EM N/A
  • EPS
  • ETON N/A
  • EM 0.01
  • Revenue
  • ETON $39,011,000.00
  • EM $261,961,935.00
  • Revenue This Year
  • ETON $107.69
  • EM N/A
  • Revenue Next Year
  • ETON $65.50
  • EM $6.16
  • P/E Ratio
  • ETON N/A
  • EM $74.86
  • Revenue Growth
  • ETON 23.29
  • EM N/A
  • 52 Week Low
  • ETON $3.03
  • EM $0.50
  • 52 Week High
  • ETON $18.41
  • EM $1.18
  • Technical
  • Relative Strength Index (RSI)
  • ETON 43.84
  • EM 50.85
  • Support Level
  • ETON $12.73
  • EM $1.11
  • Resistance Level
  • ETON $15.73
  • EM $1.14
  • Average True Range (ATR)
  • ETON 0.93
  • EM 0.02
  • MACD
  • ETON -0.01
  • EM -0.00
  • Stochastic Oscillator
  • ETON 49.67
  • EM 33.33

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.

Share on Social Networks: